Dolby Laboratories Inc (NYSE: DLB) has reported E.P.S. of $0.40 for its third fiscal quarter (ending June 30) versus $0.17 for the same period a year ago — an increase of 135%. Relative to the consensus estimate of $0.59, this was a shortfall of $-0.19. For the latest four quarters through June 30, E.P.S. were $2.23 compared to $2.29 a year ago — a decline of -3%.
Recent Price Action
Dolby Laboratories Inc (NYSE: DLB) stock closed at $73.22 on 8/7/24 after a slight decline of -0.5%. Moreover, unusually high trading volume at 196% of normal accompanied the decline. The stock has declined -6.7% during the last week and has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
DLB is expected to continue to be an important Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
Dolby Laboratories has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Dolby Laboratories has a poor Power Rating of 28 and a poor Appreciation Score of 19, triggering the Lowest Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment